Test Price
2,800 AED✅ Home Collection Available
C2 Deficiency (C2 Gene) Next-Generation Sequencing Test in UAE | 2800 AED | DHA Licensed Genetic Lab
Executive Summary & Core Metrics
Clinical precision meets patient trust: our C2 Deficiency NGS test delivers 99.9% diagnostic sensitivity through ISO 9001:2015 accredited processing. You receive paid hospital‑grade home collection with cold‑chain logistics, VIP mobile phlebotomy, and a telephonic post‑test clinical guidance session to interpret your results. Direct insurance billing verification is available via WhatsApp at +971 54 548 8731.
- 99.9% Sensitivity – ISO‑accredited NGS workflow
- Home Collection – Hospital‑grade, 8 AM‑11 PM, cold‑chain logistics
- Clinical Support – Post‑test telehealth guidance with a DHA‑licensed specialist
- Insurance – Instant verification via WhatsApp +971 54 548 8731
Test Overview & Methodology
The C2 Deficiency (C2 Gene) Next‑Generation Sequencing Test identifies pathogenic variants in the C2 gene, which encodes the complement component 2 protein. Deficiency in C2 predisposes individuals to recurrent bacterial infections and autoimmune conditions like systemic lupus erythematosus (SLE) and vasculitis. This test leverages high‑coverage NGS to sequence the entire coding region and splice junctions, ensuring accurate diagnosis.
| Feature | Our C2 NGS Test | Closest Alternative (Sanger Sequencing) |
|---|---|---|
| Methodology | Next‑Generation Sequencing (NGS) – full gene coverage including intron‑exon boundaries | Targeted Sanger sequencing – only selected exons |
| Turnaround Time | 3–4 weeks | 4–6 weeks |
| Variant Coverage | SNVs, small indels, copy‑number variants (MLPA backup) | Only known point mutations in targeted region |
| Clinical Utility | Comprehensive report with ICD‑10‑CM coding and complement pathway interpretation | Limited variant interpretation, no pathway analysis |
Physician Insight & Safety Protocols
“This genetic test provides a piece of the clinical puzzle but must be interpreted alongside a full rheumatologic and immunologic work‑up. I strongly recommend pre‑ and post‑test genetic counselling to understand the implications for family members. Your safety and accurate diagnosis remain our top priority.”
— Lina Osama Zaki Quteineh, Consultant Medical Genetics, DHA Registration ID: 9294403
⚠ Medication Advisory
Do not discontinue prescribed medication without consulting your doctor. This test is a diagnostic aid and does not replace clinical management.
Patient Safety: Exclusion Criteria & Red Flags
- Exclusion from home blood draw: Current anticoagulation therapy requires pre‑collection clearance; severe bleeding disorders (e.g., haemophilia) need hospital‑based sampling.
- Allergy to antiseptics or latex – inform the phlebotomist so alternative materials can be used.
- Red flags – seek immediate medical attention if you experience prolonged bleeding (>15 minutes), dizziness, fainting, sudden joint swelling or fever within 24 hours after the blood draw.
- For paediatric patients (minors): collection is performed only with a legal guardian present and in strict accordance with UAE medical liability regulations.
Patient FAQ & Clinical Guidance
1. What does the C2 deficiency NGS test detect?
Snippet: This DNA test identifies pathogenic mutations in the C2 gene that cause complement component 2 deficiency, a primary immunodeficiency linked to lupus and recurrent infections.
2. How is the sample collected for this test?
Snippet: A certified phlebotomist draws a small blood sample from your arm or collects a DNA‑stabilized FTA card with a quick finger‑prick, all in your home.
3. What is the expected turnaround time and reporting?
Snippet: Results are ready in 3–4 weeks with a comprehensive report coded to ICD‑10‑CM standards and an optional telehealth consultation for interpretation.
UAE Regulatory & Data Privacy Adherence
Data Privacy Framework: This service fully complies with Federal Decree‑Law No. 45 of 2021 on Personal Data Protection (PDPL) and Federal Law No. 2 of 2019 Concerning the Use of Information and Communication Technology in Health Fields. Clinical safety and patient consent are governed under Federal Decree‑Law No. 4 of 2016 on Medical Liability.
Corporate Trust: DNA Labs UAE operates under DHA Facility License No. 1143. All processes are ISO 9001:2015 certified (Certificate No. INT/EGQ/2509DA/3139).
Home Collection Hours: Daily 8 AM – 11 PM, including weekends and public holidays.
Clinical & Logistical Metadata
| Test Name | C2 Deficiency (C2 Gene) Next-Generation Sequencing Test |
| Price (AED) | 2,800 AED |
| Turnaround Time | 3–4 weeks |
| Sample Type / Matrix | Blood (Whole Blood) – VIP Mobile Phlebotomy & Temperature‑Controlled Cold‑Chain Home Collection |
| Methodology Used | Next-Generation Sequencing (NGS) |
| ICD‑10‑CM Code | D84.1 (Complement deficiency) |
| LOINC Code | 94226-8 (C2 gene mutation analysis) |
| DHA Facility License & Laboratory Address | License No. 1143 – Premises 105, Floor 1, Building 33, Dubai Healthcare City, Dubai, UAE |
دعم ثنائي اللغة متاح
التحقق من التغطية التأمينية
Check Insurance Coverage Instantly
Stop the guesswork. Send a photo of your Insurance Card and Doctor's Prescription to our DHA-Certified Verification Team on WhatsApp.
توقف عن التخمين. أرسل صورة من بطاقة التأمين ووصفة الطبيب إلى فريق التحقق المعتمد من هيئة الصحة بدبي عبر الواتساب. احصل على تحديث الحالة في دقائق.
Available in Arabic, English, Hindi & Urdu
ISMS 27001:2022
ISO Accredited
HIPAA
All reports reviewed by DHA-Certified physicians